Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RLMD US Equity

Relmada Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1553643 · FY ends Dec 31
$4.83
-0.02 (-0.41%)
USD · as of 2026-08-19 · marketstack

Short interest· FINRA consolidated · settlement 2026-07-31

6 settlement cycles
Shares short13.6M
% of shares out12.7%
Days to cover7.8
Δ vs 2026-07-15+4.4%
▲ 13.6M shares shortline top = 8.5d to cover2026-05-15: 5.5M short · 6.1d to cover2026-052026-05-29: 5.8M short · 6.1d to cover2026-052026-06-15: 6.1M short · 4.4d to cover2026-062026-06-30: 10.6M short · 3.1d to cover2026-062026-07-15: 13.0M short · 8.5d to cover2026-072026-07-31: 13.6M short · 7.8d to cover2026-07

bars = shares short · line = days to cover (own scale)

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-07-3113,563,773+4.4%1,741,9857.8
2026-07-1512,990,487+22.0%1,535,3398.5
2026-06-3010,647,441+75.7%3,471,3383.1
2026-06-156,060,018+3.8%1,369,2034.4
2026-05-295,841,074+6.4%961,5236.1
2026-05-155,487,630+2.6%898,2316.1

FINRA Rule 4560 · twice monthly, published ~a week later.

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.